TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
6h
News-Medical.Net on MSNBreast cancer deaths expected to fall in the EU and UK by 2025 across most age groupsDeath rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the ...
“This could be due to a combination of increased awareness and improvements in cancer detection and treatment. But the stark ...
3hon MSN
Death rates due to breast cancer in 2025 are set to decrease for women across most age groups in Europe, according to a new ...
Breast cancer mortality rates have stopped declining for women over 74 and under 40, largely due to rising diagnoses of ...
Arvinas stock plummets 53% on mixed data from phase III metastatic breast cancer study on lead pipeline candidate, vepdegestrant.
John Mulaney detailed the risk assessment test that helped his wife Oliva Munn discover her breast cancer diagnosis in 2023.
Surgeon General’s advisory reported that alcohol can increase cancer risk. Experts explain which drinks are healthiest and ...
The Canadian Press on MSN19h
Leaked emails show Sask. breast cancer patients can’t afford Calgary for careLeaked Saskatchewan government emails say some breast cancer patients are choosing not to go to Calgary for treatment because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results